Tuesday, September 28, 2010

Neuroskeptic: Cherry Picking 101 - the GSK way

Neuroskeptic's analysis of a dodgy GSK paper on how to improve clinical trial design - prespecifiy in your protocol a plan to throw out all the patients who respond well to placebo!

Simples.

Posted via email from Jack's posterous

1 comment:

Anonymous said...

We've known they've been on this track for several years. The FDA held a workshop several years ago and endorsed this technique (using a GSK paper). Of course the FDA employee who ran the workshop was an ex-GSK VP.